Cancer Research

For a significant portion of patients diagnosed with advanced triple-negative breast cancer, the treatment journey has long been defined by the limitations of conventional chemotherapy. This review assesses the potential of Datroway (datopotamab deruxtecan) to redefine this paradigm and emerge as a

We're joined today by Biopharma expert Ivan Kairatov, whose work sits at the intersection of technology and research and development. We'll be discussing groundbreaking new research that is shattering the long-held, simplistic view of the vaginal microbiome. This conversation will explore how a

The intricate landscape of the tumor microenvironment is increasingly recognized not as a simple collection of malignant cells, but as a complex ecosystem where cancer’s fate is dictated by a dynamic interplay with the body's own immune system. The targeting of specific immune cell subsets

A significant European collaborative initiative has made remarkable strides in understanding the intricate dance between the body's immune system and the onset of cancer, potentially unlocking a new era of predictive diagnostics. By focusing on the often-overlooked first-line defenders known as

A baffling contradiction has long stood at the heart of understanding how one of the most aggressive forms of breast cancer spreads throughout the body, but new research has finally unraveled this mystery, revealing a unique survival strategy that cancer cells use to become metastatic. For years,

Today we're joined by Ivan Kairatov, a biopharma expert with extensive experience in research and development. We'll be exploring the outcomes of a groundbreaking clinical trial that has identified a surprising new use for an old drug, offering significant relief to men undergoing hormone therapy